nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—cerebellar cortex—Parkinson's disease	0.0959	0.144	CbGeAlD
Mepivacaine—SCN8A—peripheral nervous system—Parkinson's disease	0.0451	0.0676	CbGeAlD
Mepivacaine—SCN8A—nerve—Parkinson's disease	0.0352	0.0527	CbGeAlD
Mepivacaine—SCN10A—peripheral nervous system—Parkinson's disease	0.0302	0.0452	CbGeAlD
Mepivacaine—SCN8A—hindbrain—Parkinson's disease	0.0263	0.0394	CbGeAlD
Mepivacaine—SCN10A—nerve—Parkinson's disease	0.0235	0.0352	CbGeAlD
Mepivacaine—SCN1A—hindbrain—Parkinson's disease	0.0199	0.0298	CbGeAlD
Mepivacaine—SCN2A—hindbrain—Parkinson's disease	0.0183	0.0274	CbGeAlD
Mepivacaine—SCN8A—brainstem—Parkinson's disease	0.0151	0.0226	CbGeAlD
Mepivacaine—SCN8A—forebrain—Parkinson's disease	0.0146	0.0218	CbGeAlD
Mepivacaine—SCN1A—brainstem—Parkinson's disease	0.0114	0.0171	CbGeAlD
Mepivacaine—SCN1A—forebrain—Parkinson's disease	0.011	0.0165	CbGeAlD
Mepivacaine—SCN2A—brainstem—Parkinson's disease	0.0105	0.0157	CbGeAlD
Mepivacaine—SCN2A—forebrain—Parkinson's disease	0.0101	0.0151	CbGeAlD
Mepivacaine—SCN10A—forebrain—Parkinson's disease	0.00975	0.0146	CbGeAlD
Mepivacaine—SCN8A—spinal cord—Parkinson's disease	0.00939	0.0141	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—DLG1—Parkinson's disease	0.00904	0.0285	CbGpPWpGaD
Mepivacaine—SCN3A—forebrain—Parkinson's disease	0.00889	0.0133	CbGeAlD
Mepivacaine—SCN9A—midbrain—Parkinson's disease	0.00846	0.0127	CbGeAlD
Mepivacaine—SCN8A—head—Parkinson's disease	0.00834	0.0125	CbGeAlD
Mepivacaine—SCN9A—spinal cord—Parkinson's disease	0.00825	0.0124	CbGeAlD
Mepivacaine—SCN1A—medulla oblongata—Parkinson's disease	0.00796	0.0119	CbGeAlD
Mepivacaine—SCN8A—nervous system—Parkinson's disease	0.00791	0.0118	CbGeAlD
Mepivacaine—SCN8A—central nervous system—Parkinson's disease	0.00762	0.0114	CbGeAlD
Mepivacaine—SCN5A—cardiovascular system—Parkinson's disease	0.00749	0.0112	CbGeAlD
Mepivacaine—SCN8A—cerebellum—Parkinson's disease	0.00744	0.0111	CbGeAlD
Mepivacaine—SCN9A—L1CAM interactions—DLG1—Parkinson's disease	0.00731	0.023	CbGpPWpGaD
Mepivacaine—SCN2A—medulla oblongata—Parkinson's disease	0.00731	0.0109	CbGeAlD
Mepivacaine—SCN1A—midbrain—Parkinson's disease	0.00727	0.0109	CbGeAlD
Mepivacaine—SCN1A—spinal cord—Parkinson's disease	0.0071	0.0106	CbGeAlD
Mepivacaine—SCN3A—L1CAM interactions—DLG1—Parkinson's disease	0.007	0.022	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—DLG1—Parkinson's disease	0.00672	0.0212	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—DLG1—Parkinson's disease	0.00672	0.0212	CbGpPWpGaD
Mepivacaine—SCN2A—midbrain—Parkinson's disease	0.00668	0.01	CbGeAlD
Mepivacaine—SCN4A—head—Parkinson's disease	0.00654	0.0098	CbGeAlD
Mepivacaine—SCN2A—spinal cord—Parkinson's disease	0.00651	0.00975	CbGeAlD
Mepivacaine—SCN10A—L1CAM interactions—DLG1—Parkinson's disease	0.00648	0.0204	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—DLG1—Parkinson's disease	0.00648	0.0204	CbGpPWpGaD
Mepivacaine—SCN3A—medulla oblongata—Parkinson's disease	0.00642	0.00961	CbGeAlD
Mepivacaine—SCN1A—head—Parkinson's disease	0.00631	0.00945	CbGeAlD
Mepivacaine—SCN10A—spinal cord—Parkinson's disease	0.00628	0.00941	CbGeAlD
Mepivacaine—SCN4A—nervous system—Parkinson's disease	0.0062	0.00929	CbGeAlD
Mepivacaine—SCN8A—brain—Parkinson's disease	0.00605	0.00905	CbGeAlD
Mepivacaine—SCN1A—nervous system—Parkinson's disease	0.00598	0.00895	CbGeAlD
Mepivacaine—SCN4A—central nervous system—Parkinson's disease	0.00597	0.00894	CbGeAlD
Mepivacaine—SCN3A—midbrain—Parkinson's disease	0.00587	0.00879	CbGeAlD
Mepivacaine—SCN2A—head—Parkinson's disease	0.00579	0.00867	CbGeAlD
Mepivacaine—SCN1A—central nervous system—Parkinson's disease	0.00576	0.00862	CbGeAlD
Mepivacaine—SCN3A—spinal cord—Parkinson's disease	0.00573	0.00857	CbGeAlD
Mepivacaine—SCN1A—cerebellum—Parkinson's disease	0.00563	0.00843	CbGeAlD
Mepivacaine—SCN10A—head—Parkinson's disease	0.00558	0.00836	CbGeAlD
Mepivacaine—SCN2A—nervous system—Parkinson's disease	0.00549	0.00822	CbGeAlD
Mepivacaine—SCN8A—Axon guidance—NRTN—Parkinson's disease	0.00548	0.0172	CbGpPWpGaD
Mepivacaine—SCN9A—brain—Parkinson's disease	0.00531	0.00796	CbGeAlD
Mepivacaine—SCN10A—nervous system—Parkinson's disease	0.00529	0.00793	CbGeAlD
Mepivacaine—SCN2A—central nervous system—Parkinson's disease	0.00528	0.00791	CbGeAlD
Mepivacaine—Bupivacaine—CYP2D6—Parkinson's disease	0.00521	0.356	CrCbGaD
Mepivacaine—SCN2A—cerebellum—Parkinson's disease	0.00517	0.00773	CbGeAlD
Mepivacaine—SCN10A—central nervous system—Parkinson's disease	0.0051	0.00763	CbGeAlD
Mepivacaine—SCN3A—head—Parkinson's disease	0.00509	0.00762	CbGeAlD
Mepivacaine—SCN5A—head—Parkinson's disease	0.00507	0.0076	CbGeAlD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00495	0.0156	CbGpPWpGaD
Mepivacaine—SCN3A—nervous system—Parkinson's disease	0.00482	0.00722	CbGeAlD
Mepivacaine—SCN5A—nervous system—Parkinson's disease	0.00481	0.0072	CbGeAlD
Mepivacaine—SCN4A—brain—Parkinson's disease	0.00474	0.0071	CbGeAlD
Mepivacaine—SCN3A—central nervous system—Parkinson's disease	0.00464	0.00695	CbGeAlD
Mepivacaine—SCN5A—central nervous system—Parkinson's disease	0.00463	0.00693	CbGeAlD
Mepivacaine—SCN1A—brain—Parkinson's disease	0.00457	0.00684	CbGeAlD
Mepivacaine—SCN5A—L1CAM interactions—DLG1—Parkinson's disease	0.00456	0.0143	CbGpPWpGaD
Mepivacaine—SCN3A—cerebellum—Parkinson's disease	0.00454	0.0068	CbGeAlD
Mepivacaine—SCN9A—Axon guidance—NRTN—Parkinson's disease	0.00443	0.0139	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRTN—Parkinson's disease	0.00424	0.0133	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—HSPA8—Parkinson's disease	0.00423	0.0133	CbGpPWpGaD
Mepivacaine—Ropivacaine—CYP2D6—Parkinson's disease	0.0042	0.287	CrCbGaD
Mepivacaine—SCN2A—brain—Parkinson's disease	0.0042	0.00628	CbGeAlD
Mepivacaine—SCN2A—Axon guidance—NRTN—Parkinson's disease	0.00407	0.0128	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRTN—Parkinson's disease	0.00407	0.0128	CbGpPWpGaD
Mepivacaine—SCN10A—brain—Parkinson's disease	0.00405	0.00606	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—DLG4—Parkinson's disease	0.00397	0.0125	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRTN—Parkinson's disease	0.00392	0.0124	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRTN—Parkinson's disease	0.00392	0.0124	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NRTN—Parkinson's disease	0.00391	0.0123	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00375	0.0118	CbGpPWpGaD
Mepivacaine—SCN3A—brain—Parkinson's disease	0.00369	0.00552	CbGeAlD
Mepivacaine—SCN5A—brain—Parkinson's disease	0.00368	0.00551	CbGeAlD
Mepivacaine—SCN9A—L1CAM interactions—HSPA8—Parkinson's disease	0.00342	0.0108	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—DLG1—Parkinson's disease	0.00342	0.0108	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—HSPA8—Parkinson's disease	0.00327	0.0103	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—DLG4—Parkinson's disease	0.00321	0.0101	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRTN—Parkinson's disease	0.00316	0.00995	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—HSPA8—Parkinson's disease	0.00314	0.00989	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—HSPA8—Parkinson's disease	0.00314	0.00989	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—DLG4—Parkinson's disease	0.00307	0.00966	CbGpPWpGaD
Mepivacaine—Lidocaine—CYP2D6—Parkinson's disease	0.00305	0.208	CrCbGaD
Mepivacaine—SCN1A—L1CAM interactions—HSPA8—Parkinson's disease	0.00303	0.00954	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—HSPA8—Parkinson's disease	0.00303	0.00954	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRTN—Parkinson's disease	0.00302	0.00952	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—DLG4—Parkinson's disease	0.00295	0.00928	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—DLG4—Parkinson's disease	0.00295	0.00928	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRTN—Parkinson's disease	0.0029	0.00915	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRTN—Parkinson's disease	0.0029	0.00915	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—DLG4—Parkinson's disease	0.00284	0.00895	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—DLG4—Parkinson's disease	0.00284	0.00895	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRTN—Parkinson's disease	0.0028	0.00882	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRTN—Parkinson's disease	0.0028	0.00882	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—DLG1—Parkinson's disease	0.00276	0.0087	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRTN—Parkinson's disease	0.00276	0.00869	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—GDNF—Parkinson's disease	0.00267	0.00842	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—DLG1—Parkinson's disease	0.00264	0.00832	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—IGF2—Parkinson's disease	0.00255	0.00803	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—DLG1—Parkinson's disease	0.00254	0.008	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—DLG1—Parkinson's disease	0.00254	0.008	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—DLG1—Parkinson's disease	0.00245	0.00771	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—DLG1—Parkinson's disease	0.00245	0.00771	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—DLG1—Parkinson's disease	0.00244	0.00768	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00234	0.00737	CbGpPWpGaD
Mepivacaine—Lidocaine—ABCB1—Parkinson's disease	0.00218	0.149	CrCbGaD
Mepivacaine—SCN9A—Axon guidance—GDNF—Parkinson's disease	0.00216	0.00681	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—HSPA8—Parkinson's disease	0.00213	0.00671	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—GDNF—Parkinson's disease	0.00207	0.00651	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.002	0.00629	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—GDNF—Parkinson's disease	0.00199	0.00626	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—GDNF—Parkinson's disease	0.00199	0.00626	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—DLG1—Parkinson's disease	0.00197	0.00621	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.00197	0.0062	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—GDNF—Parkinson's disease	0.00192	0.00603	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—GDNF—Parkinson's disease	0.00192	0.00603	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—GDNF—Parkinson's disease	0.00191	0.00601	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—DLG1—Parkinson's disease	0.00189	0.00594	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—DLG1—Parkinson's disease	0.00181	0.00571	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—DLG1—Parkinson's disease	0.00181	0.00571	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—DLG1—Parkinson's disease	0.00175	0.0055	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—DLG1—Parkinson's disease	0.00175	0.0055	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.00172	0.00542	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.00169	0.00533	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HSPA8—Parkinson's disease	0.0016	0.00503	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00158	0.00496	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—GDNF—Parkinson's disease	0.00154	0.00486	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00152	0.00478	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—DLG4—Parkinson's disease	0.0015	0.00472	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00149	0.0047	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—GDNF—Parkinson's disease	0.00148	0.00465	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—GRIN2B—Parkinson's disease	0.00147	0.00461	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GDNF—Parkinson's disease	0.00142	0.00447	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GDNF—Parkinson's disease	0.00142	0.00447	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GDNF—Parkinson's disease	0.00137	0.00431	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GDNF—Parkinson's disease	0.00137	0.00431	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.00135	0.00424	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00131	0.00411	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HSPA8—Parkinson's disease	0.00129	0.00407	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HSPA8—Parkinson's disease	0.00124	0.00389	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.00123	0.00387	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—DLG4—Parkinson's disease	0.00121	0.00382	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—ABL1—Parkinson's disease	0.00119	0.00376	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HSPA8—Parkinson's disease	0.00119	0.00374	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HSPA8—Parkinson's disease	0.00119	0.00374	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—GRIN2B—Parkinson's disease	0.00118	0.00373	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—DLG4—Parkinson's disease	0.00116	0.00365	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HSPA8—Parkinson's disease	0.00114	0.00361	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HSPA8—Parkinson's disease	0.00114	0.00361	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HSPA8—Parkinson's disease	0.00114	0.00359	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—GRIN2B—Parkinson's disease	0.00113	0.00357	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—DLG4—Parkinson's disease	0.00111	0.00351	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—DLG4—Parkinson's disease	0.00111	0.00351	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.0011	0.00347	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—GRIN2B—Parkinson's disease	0.00109	0.00343	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—GRIN2B—Parkinson's disease	0.00109	0.00343	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—DLG4—Parkinson's disease	0.00107	0.00338	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—DLG4—Parkinson's disease	0.00107	0.00338	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—DLG4—Parkinson's disease	0.00107	0.00337	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00106	0.00335	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—GRIN2B—Parkinson's disease	0.00105	0.00331	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—GRIN2B—Parkinson's disease	0.00105	0.00331	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—GRIN2B—Parkinson's disease	0.00105	0.00329	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—ABL1—Parkinson's disease	0.000966	0.00304	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GDNF—Parkinson's disease	0.000961	0.00303	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000944	0.00297	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—ABL1—Parkinson's disease	0.000924	0.00291	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HSPA8—Parkinson's disease	0.000922	0.0029	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000899	0.00283	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ABL1—Parkinson's disease	0.000888	0.0028	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ABL1—Parkinson's disease	0.000888	0.0028	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HSPA8—Parkinson's disease	0.000882	0.00278	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—DLG4—Parkinson's disease	0.000865	0.00272	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ABL1—Parkinson's disease	0.000856	0.0027	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ABL1—Parkinson's disease	0.000856	0.0027	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ABL1—Parkinson's disease	0.000852	0.00268	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HSPA8—Parkinson's disease	0.000847	0.00267	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HSPA8—Parkinson's disease	0.000847	0.00267	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—GRIN2B—Parkinson's disease	0.000846	0.00266	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—DLG4—Parkinson's disease	0.000827	0.00261	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HSPA8—Parkinson's disease	0.000817	0.00257	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HSPA8—Parkinson's disease	0.000817	0.00257	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—GRIN2B—Parkinson's disease	0.000809	0.00255	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.000805	0.00253	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—DLG4—Parkinson's disease	0.000795	0.0025	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—DLG4—Parkinson's disease	0.000795	0.0025	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GRIN2B—Parkinson's disease	0.000777	0.00245	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.000777	0.00245	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—DLG4—Parkinson's disease	0.000767	0.00241	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.000767	0.00241	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000755	0.00238	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GRIN2B—Parkinson's disease	0.000749	0.00236	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.000749	0.00236	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000738	0.00232	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ABL1—Parkinson's disease	0.000689	0.00217	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ABL1—Parkinson's disease	0.000659	0.00208	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ABL1—Parkinson's disease	0.000633	0.00199	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.000633	0.00199	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.000611	0.00192	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ABL1—Parkinson's disease	0.000611	0.00192	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000602	0.0019	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000574	0.00181	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—INS—Parkinson's disease	0.000563	0.00177	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000539	0.0017	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000533	0.00168	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000531	0.00167	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000527	0.00166	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—INS—Parkinson's disease	0.000456	0.00143	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—INS—Parkinson's disease	0.000436	0.00137	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000429	0.00135	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—INS—Parkinson's disease	0.000419	0.00132	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—INS—Parkinson's disease	0.000419	0.00132	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—INS—Parkinson's disease	0.000404	0.00127	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—INS—Parkinson's disease	0.000404	0.00127	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000386	0.00122	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—Parkinson's disease	0.000345	0.00109	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000312	0.000982	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—Parkinson's disease	0.000305	0.00096	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—INS—Parkinson's disease	0.000284	0.000894	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—Parkinson's disease	0.000279	0.000878	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—Parkinson's disease	0.000267	0.00084	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—Parkinson's disease	0.000256	0.000807	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—Parkinson's disease	0.000256	0.000807	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—Parkinson's disease	0.000247	0.000778	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—Parkinson's disease	0.000247	0.000778	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—Parkinson's disease	0.000247	0.000777	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—Parkinson's disease	0.000246	0.000775	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—Parkinson's disease	0.000236	0.000743	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—Parkinson's disease	0.000227	0.000714	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—Parkinson's disease	0.000227	0.000714	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—Parkinson's disease	0.000219	0.000688	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—Parkinson's disease	0.000219	0.000688	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—Parkinson's disease	0.000199	0.000627	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—Parkinson's disease	0.00019	0.0006	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—Parkinson's disease	0.000183	0.000576	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—Parkinson's disease	0.000183	0.000576	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—Parkinson's disease	0.000176	0.000555	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—Parkinson's disease	0.000176	0.000555	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—Parkinson's disease	0.000174	0.000547	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—Parkinson's disease	0.000154	0.000484	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—Parkinson's disease	0.000124	0.000391	CbGpPWpGaD
